RxDoctor Payments Data

Eve Knapp, MD

Family Medicine · Greensboro, NCNPI 1013095033

Payments from drug & device makers

$8,571in general payments, 2019–2025

Across 505 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$1K
  • AstraZeneca$753
  • Lilly USA, LLC$677
  • Novo Nordisk$602
  • Amgen$560
  • Viiv Healthcare Company$413
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$8,571100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead59$1,119
AstraZeneca42$753
Lilly USA, LLC44$677
Novo Nordisk45$602
Amgen39$560
Viiv Healthcare Company24$413
AbbVie21$409
Boehringer Ingelheim21$354
Pfizer22$351
GSK15$300
Abbott15$282
Merck15$240
Takeda Pharmaceuticals U.S.A., Inc.15$210
Astellas Pharma US Inc16$196
Johnson & Johnson(2 entities)11$178
Exact Sciences5$165
Bayer9$161
Sanofi-aventis U.S. LLC9$157
Otsuka America Pharmaceutical, Inc.6$130
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$86
Esperion Therapeutics, Inc.5$80
Biohaven Pharmaceutical Holding Company Ltd.4$76
Amarin Pharma, Inc.4$66
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$65
Globus Medical2$52
Kowa Pharmaceuticals America, Inc.4$49
Teva Pharmaceuticals USA, Inc.3$43
Biohaven Pharmaceuticals, Inc.2$39
Eisai Inc.2$37
Dexcom, Inc.2$36
Redhill Biopharma Inc.2$36
Intra-sana Laboratories1$36
Dynavax Technologies Corporation2$35
Xeris Pharmaceuticals, Inc.2$33
Cepheid2$32
Arbor Pharmaceuticals, Inc.2$32
Corcept Therapeutics1$28
Mylan Specialty L.p.1$27
Irhythm Technologies, Inc.1$26
Ironshore Pharmaceuticals Inc.2$26
IBSA Pharma Inc.1$25
Daiichi Sankyo Inc.1$25
Tris Pharma Inc1$22
Invivyd Inc1$22
Hologic Sales And Service, LLC1$22
Otsuka Pharmaceutical Development & Commercialization, Inc.1$22
Antares Pharma, Inc.1$22
Endo Pharmaceuticals Inc.1$21
Viatris Specialty LLC1$20
Idorsia Pharmaceuticals US Inc1$19
Novartis1$19
E.r. Squibb & Sons, L.L.C.1$18
Tactile Systems Technology Inc1$17
Currax Pharmaceuticals LLC1$16
Inspire Medical Systems, Inc.1$16
Corium, LLC1$15
Clarus Therapeutics Inc.1$15
Radius Health, Inc.1$14
Amneal Pharmaceuticals LLC1$12
Genentech USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,571 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$62,753
Medicare patients
83
Services billed
1,144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide25$27,169
OzempicSemaglutide26$24,716
JardianceEmpagliflozin24$18,753
MyrbetriqMirabegron12$12,615
Bydureon BciseExenatide Microspheres11$8,820
SynthroidLevothyroxine Sodium62$6,085
TradjentaLinagliptin11$5,986
BelsomraSuvorexant11$5,022
PaxlovidNirmatrelvir/Ritonavir15$2,829
Rosuvastatin Calcium185$1,954
Atorvastatin Calcium196$1,894
Omega-3 Acid Ethyl Esters16$1,847
Omeprazole65$1,201
Potassium Chloride19$1,067
Metformin Hcl ErMetformin Hcl73$946

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$677$27,16925 claims
Boehringer IngelheimJardiance, Tradjenta$354$24,73835 claims
Novo NordiskOzempic$602$24,71626 claims
Astellas Pharma US IncMyrbetriq$196$12,61512 claims
AbbVieSynthroid$409$6,08562 claims
MerckBelsomra$240$5,02211 claims
PfizerPaxlovid$351$2,82915 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$12$50468 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →